搜尋
Can Fite Biopharma Ltd
CANF添加自選
4.700USD
+1.730+58.25%
收盤 07/01, 16:00（美東）報價延遲15分鐘
41.02K總市值
虧損本益比TTM
關於 Can Fite Biopharma Ltd 公司
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltd簡介
公司代碼CANF
公司名稱Can Fite Biopharma Ltd
上市日期Sep 22, 2005
CEOFishman (Pnina)
員工數量5
證券類型Depository Receipt
年結日Sep 22
公司地址10 Bareket Street, Kiryat Matalon
城市PETAH TIKVA
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家Israel
郵編49170
電話97239241114
網址https://www.canfite.com/
公司代碼CANF
上市日期Sep 22, 2005
CEOFishman (Pnina)
Can Fite Biopharma Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
常見問題
Can Fite Biopharma Ltd的前五大股東是誰？
Can Fite Biopharma Ltd的前五大股東如下：Dr. Sari Fishman, Ph.D.
有多少機構持有Can Fite Biopharma Ltd(CANF)的股份？
截至2026Q1，共有28家機構持有Can Fite Biopharma Ltd的股份，合計持有的股份價值約為32.13K，占公司總股份的1.50% 。與2025Q4相比，機構持股有所增加，增幅為-81636.00。